Abstract:Silencing type information regulator homolog 1 (SIRT1) is a class of nicotinamide adenine dinucleotide (NAD+) dependent deacetylases, which is the convergence point of important physiological processes in vivo, namely, osteoblast aging, energy metabolism, and bone remodeling. To verify whether the O-acetylglucosamine (O-GlcNAc) modification of SIRT1 in the nucleus of osteoblasts enhances its deacetylase activity under stress and protects osteoblasts through the RANK/RANKL signaling pathway by collagen deacetylation. The R language and online data research identified SIRT1 as being involved in bone metabolism. Enrichment analysis showed that SIRT1 is involved in osteoblast transcription, apoptosis, and deacetylation pathways. Interactive Immuno-blotting and immunofluorescence experiments revealed that SIRT1 and O-glycosylation catalytic enzyme (OGT) were localized in the nucleus. Mass Spectrometry analysis showed that O-glycosylation occurred on the asparagine at the 346th position of SIRT1, and N346th was located in the central domain of SIRT1. Furthermore, the protein structure analysis of PyMol also proved that the OGT binding region was in the central domain of SIRT1. Under physiological conditions, both wtSIRT1 and SIRT1N346R can inhibit RANKL-mediated transcriptional activation. The RT-PCR detection results showed that wtSIRT1 reduced RANKL transcription under the conditions of apoptotic agent treatment. The finding that SIRT1 can regulate the physiological process of bone remodeling through the RANK/RANKL signaling pathway in osteoblasts under stress. The O-glycosylation and deacetylation activity of SIRT1 significantly increased, regulating the balance between osteoblast survival and apoptosis by deacetylation of key proteins such as RANKL.

Sirt1: An Increasingly Interesting Molecule with a Potential Role in Bone Metabolism and Osteoporosis

Role of Sirtuins in Bone Biology: Potential Implications for Novel Therapeutic Strategies for Osteoporosis.

SIRT3: A Potential Target of Different Types of Osteoporosis

Sirtuins mediate mitochondrial quality control mechanisms: a novel therapeutic target for osteoporosis

Cellular senescence as a key factor in osteoporosis: the role of SIRT1

Role of SIRT3 in Bone Homeostasis and Its Application in Preventing and Treating Bone Diseases

SIRT1 maintains bone homeostasis by regulating osteoblast glycolysis through GOT1

Reversing the Imbalance in Bone Homeostasis Via Sustained Release of SIRT-1 Agonist to Promote Bone Healing under Osteoporotic Condition

SIRT1 Signaling Pathways in Sarcopenia: Novel Mechanisms and Potential Therapeutic Targets

SIRT1 and ZNF350 as novel biomarkers for osteoporosis: a bioinformatics analysis and experimental validation

Role of Biomolecules in Osteoclasts and Their Therapeutic Potential for Osteoporosis

SIRT1/FOXO3a Axis Plays an Important Role in the Prevention of Mandibular Bone Loss Induced by 1,25(OH)2D Deficiency

SIRT1 Asn346 sugar chain promoting collagen deacetylation protective effect on osteoblasts under stress

Modulation of SIRT6 Activity Acts As an Emerging Therapeutic Implication for Pathological Disorders in the Skeletal System

Novel Role of the SIRT1 in Endocrine and Metabolic Diseases

Sirtuins: exploring next-gen therapeutics in the pathogenesis osteoporosis and associated diseases

SIRT2 Deficiency Prevents Age-Related Bone Loss in Rats by Inhibiting Osteoclastogenesis.

Research progress on Sirtuins (SIRTs) family modulators

SIRT1 and Energy Metabolism

Sirtuins: Key players in obesity-associated adipose tissue remodeling

SIRT1 in metabolic syndrome: where to target matters.